PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip W Kanthoff, MD
Dana-Faber Cancer Institut
Principal Investigator - Thomas J Schuetz, MD
Therion Biologics Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Urology Centers of Alabama
Homewood, Alabama, United States
- Alaska Clinical Research Center
Anchorage, Alaska, United States
- Urology Associates of Central California
Fresno, California, United States
- San Diego Urology Center
La Mesa, California, United States
- Loma Linda University
Loma Linda, California, United States
- Atlantic Urology Medical Group
Long Beach, California, United States
- Pacific Clinical Research
Santa Monica, California, United States
- Western Clinical Research, Inc.
Torrance, California, United States
- Uchsc Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Connecticut Clinical Research Center
Waterbury, Connecticut, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- South Florida Medical Research
Aventura, Florida, United States
- Advanced Research Institute
New Port Richey, Florida, United States
- Midtown Urology
Atlanta, Georgia, United States
- North Idaho Urology
Coeur d'Alene, Idaho, United States
- Prairie Medical Associates, Ltd.
Chicago, Illinois, United States
- Medical and Surgical Specialists
Galesburg, Illinois, United States
- Osf Saint Francis Medical Center
Peoria, Illinois, United States
- Carle Clinic Cancer Center
Urbana, Illinois, United States
- Metropolitan Urology
Jeffersonville, Indiana, United States
- Urologic Associates, Pc
Davenport, Iowa, United States
- Franklin Square Hospital Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Lawrenceville Urology
Lawrenceville, New Jersey, United States
- the Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Urology Group of New Mexico
Albuquerque, New Mexico, United States
- the Urological Institute of Northeastern New York
Albany, New York, United States
- Accumed Research Associates
Garden City, New York, United States
- Columbia Presbyterian Medical Center
New York, New York, United States
- Nyack Hospital
Nyack, New York, United States
- the Urology Center
Greensboro, North Carolina, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Charleston Cancer Center
Charleston, South Carolina, United States
- Urology Associates Clinical Research
Nashville, Tennessee, United States
- Arlington Cancer Center
Arlington, Texas, United States
- Urology Clinic of North Texas, Pa
Dallas, Texas, United States
- Texas Cancer Center
Fort Worth, Texas, United States
- Texas Cancer Care
Weatherford, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2003
- Primary completion
- 4 Jan 2006
- Completion
- 31 Jan 2009
- Last update posted
- 11 Sept 2017
- Registered enrollment
- 120
- Registry id
- NCT00078585
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.